Safety and antitumor activity of sitravatinib in combination with tislelizumab in patients with advanced solid tumors: Ovarian cancer cohort data

B. Gao, J. Goh, B. Markman, M. Voskoboynik, H. K. Gan, J. Coward, D. Palmieri, J. So, T. Meniawy, C. Chen, X. Xiang, J. Qiu, Y. Xu, L. Yang, M. Millward

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Number of pages2
JournalAnnals of Oncology
Publication statusPublished - Dec 2019
EventImmuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO) - Geneva, Switzerland
Duration: 11 Dec 201914 Dec 2019

Cite this